StreetInsider.com News Articles

Form 8-K Bone Biologics Corp For: Sep 10

Wed, 16 Sep 2026 17:01:00 -0400

si-local-file:///var/storage/secattach/20260916/27071040.html

Bone Biologics adds three Australian trial sites for NB1 spinal study

Tue, 08 Sep 2026 08:32:36 -0400

Bone Biologics Corporation (Nasdaq: BBLG, BBLGW) has expanded its first-in-human pilot clinical trial of NB1 to six hospital sites in Australia, doubling the number of participating centers, according to a company press release.

NB1 combines the recombinant human NELL-1 protein (rhNELL-1) with demineralized bone matrix for use in spinal fusion procedures. The addition of three sites is intended to broaden patient access and reduce dependence on patient flow at any single center, with the company stating it expects to complete enrollment by year-end 2026.

The pilot study is a multicenter, prospective, randomized trial evaluating the safety and preliminary effectiveness of NB1 in

Bone Biologics Expands Trial Sites

Tue, 08 Sep 2026 08:30:00 -0400

Addition of three sites strengthens expectation to complete enrollment by year-end 2026

BURLINGTON, MA, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Bone Biologics Corporation (Nasdaq: BBLG, BBLGW) (“Bone Biologics” or the “Company”), a developer of orthobiologic products for spine fusion markets, today announced that six hospital sites in Australia are now under agreement to participate in its first-in-human pilot clinical trial of NB1, the Company’s rhNELL-1-based bone graft product for spinal fusion. The expanded network doubles the number of participating centers and is expected to accelerate patient screening and surgical scheduling, strengthening the Company’s expectation to complete enrollment by

Bone Biologics Expands Trial Sites

Tue, 08 Sep 2026 08:30:00 -0400

Addition of three sites strengthens expectation to complete enrollment by year-end 2026

Bone Biologics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

Thu, 03 Sep 2026 08:30:00 -0400

BURLINGTON, MA, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Bone Biologics Corporation ("Bone Biologics" or the "Company") (NASDAQ: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets, today announced that it will participate in the H.C. Wainwright 28^th Annual Global Investment Conference. The conference is being held on September 14 – 16, 2026 at the Lotte New York Palace Hotel.

Jeff Frelick, Chief Executive Officer of Bone Biologics will hold one-on-one meetings with investors on September 14 – 16. A virtual presentation will be available on-demand starting Friday, September 11 at 7:00 AM ET. The presentation will be

Bone Biologics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

Thu, 03 Sep 2026 08:30:00 -0400

Form DEF 14A Bone Biologics Corp For: Aug 28

Fri, 28 Aug 2026 17:27:00 -0400

si-local-file:///var/storage/secattach/20260828/26999186.html

Form DEF 14A Bone Biologics Corp For: Aug 28

Fri, 28 Aug 2026 17:27:00 -0400

si-local-file:///var/storage/secattach/20260828/26999186.html

Form PRE 14A Bone Biologics Corp For: Aug 18

Tue, 18 Aug 2026 17:01:00 -0400

si-local-file:///var/storage/secattach/20260818/26945240.html

Form PRE 14A Bone Biologics Corp For: Aug 18

Tue, 18 Aug 2026 17:01:00 -0400

si-local-file:///var/storage/secattach/20260818/26945240.html

Form 10-Q Bone Biologics Corp For: Jun 30

Fri, 14 Aug 2026 17:02:00 -0400

si-local-file:///var/storage/secattach/20260814/26932453.html

Form 10-Q Bone Biologics Corp For: Jun 30

Fri, 14 Aug 2026 17:02:00 -0400

si-local-file:///var/storage/secattach/20260814/26932453.html

Form EFFECT Bone Biologics Corp

Mon, 27 Jul 2026 06:03:00 -0400

si-local-file:///var/storage/secattach/20260727/26815438.html

Form EFFECT Bone Biologics Corp

Mon, 27 Jul 2026 06:03:00 -0400

si-local-file:///var/storage/secattach/20260727/26815438.html

Form 424B3 Bone Biologics Corp

Fri, 24 Jul 2026 17:01:00 -0400

si-local-file:///var/storage/secattach/20260724/26814218.html

Form 424B3 Bone Biologics Corp

Fri, 24 Jul 2026 17:01:00 -0400

si-local-file:///var/storage/secattach/20260724/26814218.html

Form 8-K Bone Biologics Corp For: Jul 23

Thu, 23 Jul 2026 08:05:00 -0400

si-local-file:///var/storage/secattach/20260723/26805027.html

Form 8-K Bone Biologics Corp For: Jul 23

Thu, 23 Jul 2026 08:05:00 -0400

si-local-file:///var/storage/secattach/20260723/26805027.html

Form DEFA14A Bone Biologics Corp

Mon, 20 Jul 2026 17:15:00 -0400

si-local-file:///var/storage/secattach/20260720/26790450.html

Form DEFA14A Bone Biologics Corp

Mon, 20 Jul 2026 17:15:00 -0400

si-local-file:///var/storage/secattach/20260720/26790450.html

Form S-3 Bone Biologics Corp

Fri, 17 Jul 2026 17:14:00 -0400

si-local-file:///var/storage/secattach/20260717/26785142.html

Form S-3 Bone Biologics Corp

Fri, 17 Jul 2026 17:14:00 -0400

si-local-file:///var/storage/secattach/20260717/26785142.html

Form 8-K Bone Biologics Corp For: Jul 15

Thu, 16 Jul 2026 17:25:00 -0400

si-local-file:///var/storage/secattach/20260716/26780673.html

Form 8-K Bone Biologics Corp For: Jul 15

Thu, 16 Jul 2026 17:25:00 -0400

si-local-file:///var/storage/secattach/20260716/26780673.html

Form 8-K Bone Biologics Corp For: Jul 07

Thu, 09 Jul 2026 16:30:00 -0400

si-local-file:///var/storage/secattach/20260709/26753604.html